J. Dunn

发表

Looking at CER from Medicare’s Perspective

C. Huff, J. Dunn, 2012, Journal of managed care pharmacy : JMCP.

Translating Atopic Dermatitis Management Guidelines Into Practice for Primary Care Providers

S. Feldman, A. Paller, E. Simpson, 2015, Pediatrics.

Utilization and Drug Cost Outcomes of a Step-Therapy Edit for Generic Antidepressants in an HMO in an Integrated Health System

J. Dunn, F. Curtiss, E. Cannon, 2006, Journal of managed care pharmacy : JMCP.

Anaphylaxis: a payor's perspective on epinephrine autoinjectors.

J. Dunn, D. Sclar, 2014, The American journal of medicine.

Managed care interventions for improving outcomes in acute heart failure syndromes.

M. Gheorghiade, G. Fonarow, J. Dunn, 2008, The American journal of managed care.

Table of Contents “ This Drug May Work , But Is It Worth the Cost ? ” Can Comparative Effectiveness Research Help Tame Rising Health Care Costs ?

John B. Watkins, A. Holtorf, D. Brixner, 2012 .

Implementing CER: what will it take?

A. Holtorf, J. Biskupiak, J. Dunn, 2012, Journal of managed care pharmacy : JMCP.

Considerations about risk of ongoing distress: what can we learn from repeat screening?

S. Chambers, J. Dunn, C. Seib, 2021, Supportive Care in Cancer.

Pay for Performance: Where's The Return?

J. Dunn, S. Cornell, M. O’Kane, 2015 .

Major Comorbidities of Atopic Dermatitis: Beyond Allergic Disorders

J. C. Jaworski, S. Feldman, A. Paller, 2018, American Journal of Clinical Dermatology.

Description of the outcomes of prior authorization of palivizumab for prevention of respiratory syncytial virus infection in a managed care organization.

J. Dunn, Matt Mitchell, Sushma Patel, 2010, Journal of managed care pharmacy : JMCP.

Managed care considerations.

J. Dunn, 2008, The American journal of managed care.

Myelodysplastic syndromes: health care management considerations.

J. Dunn, A. J. Kogan, 2009, Managed care.

Pharmacological treatments for BCG-refractory cancer of the urinary bladder

Sam S. Chang, Michael Cookson, A. Bronstone, 2008 .

The burden of hyperkalemia in patients with cardiovascular and renal disease.

J. Dunn, R. Adamson, W. Benton, 2015, The American journal of managed care.

Advances in vaccine technology and their impact on managed care.

J. McCullers, J. Dunn, 2008, P & T : a peer-reviewed journal for formulary management.

Payer and provider collaborations that improve quality outcomes in oncology.

D. Nash, J. Dunn, L. Schwartzberg, 2010, Managed care.

A Comparison of the Clinical Effectiveness and Cost-Effectiveness of Treatments for Moderate to Severe Psoriasis

A. Bronstone, G. Goldenberg, J. Dunn, 2010 .

Translating clinical guidelines into practice: the effective and appropriate use of human growth hormone.

Peter A. Lee, J. Dunn, R. Rapaport, 2013, The American journal of managed care.

Oncology Pharmacy Management and the Evolving Role of Managed Care: Recommendations for a Changing Environment with a Focus on Multiple Myeloma

C. Mullins, C. Huff, J. Dunn, 2012, Journal of Managed Care Pharmacy : JMCP.

Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with Hyperkalemia

J. Butler, B. Pitt, N. Oestreicher, 2018, PharmacoEconomics.

Impact of glycemic control on healthcare resource utilization and costs of type 2 diabetes: current and future pharmacologic approaches to improving outcomes.

M. Banerji, J. Dunn, 2013, American health & drug benefits.

Development of a Complementary and Alternative Medicine (CAM) Pharmacy and Therapeutics (PandT) Subcommittee and CAM Guide for Providers

J. Dunn, L. Shane-McWhorter, H. Cannon, 2005, Journal of managed care pharmacy : JMCP.

How drug life-cycle management patent strategies may impact formulary management.

J. Dunn, J. Berger, K. R. Karst, 2017, The American journal of managed care.

A claims-based view of health care charges and utilization for commercially insured patients with osteoarthritis.

J. Dunn, M. Pill, 2009, Managed care.

Patients with obsessive-compulsive disorder vs depression have comparable health care costs: a retrospective claims analysis of Florida Medicaid enrollees.

E. Hollander, D. Dougherty, D. Sheehan, 2011, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

“This Drug May Work, But Is It Worth the Cost?” Can Comparative Effectiveness Research Help Tame Rising Health Care Costs?

John B. Watkins, A. Holtorf, D. Brixner, 2015 .

Adequacy of Pharmacotherapy Among Medicaid-Enrolled Patients Newly Diagnosed with Obsessive-Compulsive Disorder

E. Hollander, D. Dougherty, D. Sheehan, 2009, CNS Spectrums.

Mapping San Jacinto Battleground, 1836-1855

J. Dunn, 2011 .

Applying Oncology Formulary and Benefit Design Innovations to the Management of Multiple Myeloma in the Managed Care Setting

C. Mullins, J. Dunn, 2012, Journal of managed care pharmacy : JMCP.

Quetiapine for treatment-resistant delirium.

Sanjay Gupta, J. Dunn, T. Newmark, 2003, Psychosomatics.

Innovations to the Management of Multiple Myeloma in the Managed Care Setting

C. Mullins, J. Dunn, 2012 .